1. Home
  2. AFMD
  3. AFMD News

Latest Affimed N.V. (AFMD) News on May 25, 2024

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024

GlobeNewswire

2 days ago

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024

GuruFocus.com

7 months ago

Thomson Reuters StreetEvents

7 months ago

Q3 2023 Fennec Pharmaceuticals Inc Earnings Call

Share on Social Networks: